MUFG Securities EMEA’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
MUFG Securities EMEA's BIIB Position: Q2 2026 in Review
MUFG Securities EMEA reduced its Biogen (BIIB) stake by 4.5% in Q2 2026, selling an estimated $51.6K and leaving 5,747 shares worth $1.24M. The position accounts for 0.01% of the portfolio, ranked #379.
MUFG Securities EMEA first reported a position in BIIB in Q4 2017 and has held it in 21 quarters since. The position peaked at $57.3M in Q4 2018. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- MUFG Securities EMEA held 5,747 shares of Biogen worth $1.24M as of Q2 2026.
- MUFG Securities EMEA sold 270 Biogen shares in Q2 2026, an estimated $51.6K.
- Biogen made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #379 holding.
- MUFG Securities EMEA first reported a position in Biogen in Q4 2017 and has held it in 21 quarters since.
- MUFG Securities EMEA's Biogen position peaked at $57.3M in Q4 2018.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.